Schonfeld Strategic Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-127,592
| Closed | -$195K | – | 1890 |
|
|
2025
Q1 | $195K | Sell |
127,592
-4,303
| -3% | -$6.58K | ﹤0.01% | 1819 |
|
|
2024
Q4 | $327K | Buy |
+131,895
| New | +$327K | ﹤0.01% | 1515 |
|
|
2024
Q3 | – | Sell |
-35,300
| Closed | -$38.8K | – | 1845 |
|
|
2024
Q2 | $38.8K | Buy |
+35,300
| New | +$38.8K | ﹤0.01% | 1819 |
|
|
2023
Q4 | – | Sell |
-269,746
| Closed | -$1.85M | – | 1741 |
|
|
2023
Q3 | $1.85M | Sell |
269,746
-184,665
| -41% | -$1.26M | 0.01% | 739 |
|
|
2023
Q2 | $4.71M | Sell |
454,411
-115,832
| -20% | -$1.2M | 0.04% | 503 |
|
|
2023
Q1 | $4.61M | Buy |
570,243
+158,005
| +38% | +$1.28M | 0.04% | 465 |
|
|
2022
Q4 | $6.49M | Buy |
412,238
+12,078
| +3% | +$190K | 0.05% | 409 |
|
|
2022
Q3 | $6.3M | Sell |
400,160
-36,100
| -8% | -$568K | 0.05% | 454 |
|
|
2022
Q2 | $6.09M | Sell |
436,260
-36,500
| -8% | -$510K | 0.06% | 384 |
|
|
2022
Q1 | $8.15M | Sell |
472,760
-17,700
| -4% | -$305K | 0.07% | 288 |
|
|
2021
Q4 | $7.13M | Sell |
490,460
-22,415
| -4% | -$326K | 0.06% | 339 |
|
|
2021
Q3 | $9.23M | Buy |
512,875
+258,531
| +102% | +$4.65M | 0.1% | 250 |
|
|
2021
Q2 | $4.47M | Sell |
254,344
-113,048
| -31% | -$1.98M | 0.05% | 466 |
|
|
2021
Q1 | $9.26M | Buy |
367,392
+60,492
| +20% | +$1.52M | 0.11% | 221 |
|
|
2020
Q4 | $1.99M | Buy |
306,900
+57,700
| +23% | +$373K | 0.03% | 569 |
|
|
2020
Q3 | $641K | Buy |
249,200
+53,100
| +27% | +$137K | 0.01% | 797 |
|
|
2020
Q2 | $318K | Buy |
196,100
+173,834
| +781% | +$282K | 0.01% | 929 |
|
|
2020
Q1 | $23K | Buy |
+22,266
| New | +$23K | ﹤0.01% | 1072 |
|
|
2018
Q4 | – | Sell |
-65,000
| Closed | -$944K | – | 1034 |
|
|
2018
Q3 | $944K | Sell |
65,000
-100
| -0.2% | -$1.45K | 0.04% | 438 |
|
|
2018
Q2 | $1.3M | Buy |
65,100
+19,272
| +42% | +$385K | 0.07% | 348 |
|
|
2018
Q1 | $804K | Buy |
+45,828
| New | +$804K | 0.06% | 376 |
|
|
2017
Q3 | – | Sell |
-40,000
| Closed | -$1.09M | – | 547 |
|
|
2017
Q2 | $1.09M | Sell |
40,000
-8,277
| -17% | -$225K | 0.11% | 262 |
|
|
2017
Q1 | $1.44M | Buy |
+48,277
| New | +$1.44M | 0.14% | 199 |
|